1. Institute of Biomedical Chemistry, Russian Academy of Medical Sciences 2. Institute of Rheumatology; Russian Academy of Medical Sciences 3. Russian State Medical University, Moscow
A new phospholipid drug "Posphogliv" showed earlier good results in the treatment of liver discases. The mechanism of its effect consists in non-specific repair of biomembranes. In the present study it was used for the treatment of in patients with psoriatic arthritis, accompanied by severe damages of blood rheology. The group of patients took Phosphogliv 3 months in the dose of 0.6 g per day. Considerable decrease of erythrocytes aggregability was observed after the treatment. There were no changes in total blood viscosity. The clinical state of patients markedly improved after the treatment. Simultaneous decrease of blood C-reactive protein level suggests weakening of inflammation. The mechanism of these effects may involve direct influence of the phospholipid on erythrocyte membranes and/or with indirect influence through the improvement of liver function. The results show that Phosphogliv inclusion into therapy improved the state of patiens with psoriatic arthritis. The results of the present study also indicate principal possibility of broadening of clinical use of this drug. Its positive effects are based on membrane reparative properties of polyunsaturated phosphatidylcholine in combination with anti-inflammatory and immunomodulative effects of its second component, glycyrrhizin acid.
Download PDF:
Citation:
Ipatova O.M., Nasonov E.L., Korotaeva T.V., Firsov N.N., Ivkina O.A., Torkhovskaya T.I., Archakov A.I. (2003) Hemorheological and clinical efficiency of new phospholipid hepatoprotective drug "Phosphogliv" in patients with psoriatic arthritis. Biomeditsinskaya Khimiya, 49(5), 484-490.
Ipatova O.M. et al. Hemorheological and clinical efficiency of new phospholipid hepatoprotective drug "Phosphogliv" in patients with psoriatic arthritis // Biomeditsinskaya Khimiya. - 2003. - V. 49. -N 5. - P. 484-490.
Ipatova O.M. et al., "Hemorheological and clinical efficiency of new phospholipid hepatoprotective drug "Phosphogliv" in patients with psoriatic arthritis." Biomeditsinskaya Khimiya 49.5 (2003): 484-490.
Ipatova, O. M., Nasonov, E. L., Korotaeva, T. V., Firsov, N. N., Ivkina, O. A., Torkhovskaya, T. I., Archakov, A. I. (2003). Hemorheological and clinical efficiency of new phospholipid hepatoprotective drug "Phosphogliv" in patients with psoriatic arthritis. Biomeditsinskaya Khimiya, 49(5), 484-490.
References
Kelsell D., Dunlop J., Hodgins M. (2001) Trends Cell Biol, 11, 2- 6. Scholar google search
Ploeger В., Mensinga Т., Sips A. et al. (2001) Drug Metab Rev., 33, 125- 147. Scholar google search
Сторожаков Г.И., Байкова И.Е., Никитин И.Г., Арчаков A.M., Ипатова О.М. (2003) Клинич. перспективы гастроэнтерологии и гепатологии, 1. Scholar google search
Учайкин В.Ф., Дунаевский О.А., Лучшее В.И., Жаров С.Н., Ипатова О.М., и др. (2000) Клин, мед., 56, 39- 42. Scholar google search
Ипатова О.М., Арчаков А.И., Учайкин В.Ф., Торховская Т.И. (2001) Российский гастроэнтерологический журнал, 2, 127. Scholar google search
Арчаков А.И., Сельцовский Ф.П., Ипатова О.М., Торховская Т.И. и др. (2002) Вопр. мед. химии, 48, 139- 151. Scholar google search
Насонова В.А., Бурдейный А.П., Kopomaeea T.B. (1992) В сб.: Материалы научной конференции “Эссенциальные” фосфолипиды. Липостабил. Москва, с. 96-102. Scholar google search
Насонов Е.Л., Фирсов Н.Н., Kopomaeea Т.В. и др. (2003) В сб.: Материалы Международной Конференции “Гемореология и Микроциркуляция”, Ярославль, с. 72. Scholar google search
Kopomaeea T.B., Фирсов Н.Н., Выгилова М.А. и др. (2000) Тер. архив, 5, 55- 57. Scholar google search
Фирсов Н.Н., Kopomaeea T.B., Вышлова М.А. (2000) Реологические исследования в медицине, 2, 136- 141. Scholar google search
La Marne J., Wollenberg G.K., Gonias S.L., Hayes M.A. (1991) Lab. Invest. 65. Scholar google search
Firsov N.N., Bjelle A., Korotaeva T.V. et.al. (1998) Clinical Hemorheology and Microcirculation 18, 87- 97. Scholar google search
Сирко И.В. (1997). Количественные характеристики агрегационного взаимодействия эритроцитов и их применение в клинике: Автореф. дисс.канд. мед.наук. - М.. Scholar google search
Lademann J., Weigmann H.- J., Sterry W., et. al. (1999) Laser Physics, 9, 357- 362. Scholar google search
Ritchie D.M., Boyle L.A., Mclnnes G.M. et. al. (1968) Quarterly J. Med., 37, 393- 406. Scholar google search
Насонов Е.Л., Чичасова К.В., Имаметдинова Г.Р. (2001) Методы оценки поражения суставов, активности заболевания и функционального состояния больных ревматоидным артритом. Методическое пособие для врачей. Москва. Scholar google search
Goata G., Lombrandini R., Santilli F. et ah (1991) Clin. and Exp. Hypertens., 10, 232,. Scholar google search
